Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Giorgia Gazzaroli, Andrea Angeli, Arianna Giacomini & Roberto Ronca. (2023) Proteasome inhibitors as anticancer agents. Expert Opinion on Therapeutic Patents 0:0, pages 1-22.
Read now
Read now
Articles from other publishers (10)
Nancy Wilson, Shannon Reese, Lucy Ptak, Fahad Aziz, Sandesh Parajuli, Vadim Jucaud, Shari Denham, Ameet Mishra, Marilia Cascalho, Jeffrey L. Platt, Peiman Hematti & Arjang Djamali. (2023) Ixazomib for Desensitization (IXADES) in Highly Sensitized Kidney Transplant Candidates: A Phase II Clinical Trial. Kidney360 4:6, pages e796-e808.
Crossref
Crossref
Mehdi Eshraghi, Mazaher Ahmadi, Saeid Afshar, Shahrokh Lorzadeh, Aida Adlimoghaddam, Nahid Rezvani Jalal, Ryan West, Sanaz Dastghaib, Somayeh Igder, Seyed Reza Naeimi Torshizi, Amir Mahmoodzadeh, Pooneh Mokarram, Tayyebeh Madrakian, Benedict C. Albensi, Marek J. Łos, Saeid Ghavami & Stevan Pecic. (2022) Enhancing autophagy in Alzheimer's disease through drug repositioning. Pharmacology & Therapeutics 237, pages 108171.
Crossref
Crossref
Cuiling Ding, Wanda Tang, Binghui Xia, Haoran Peng, Yan Liu, Jiaqi Wang, Xu Zheng, Yangang Liu, Lanjuan Zhao, Yanhua He, Zhongtian Qi, Hao Ren, Hailin Tang & Ping Zhao. (2022) High-Throughput Screening of FDA-Approved Drug Library Reveals Ixazomib Is a Broad-Spectrum Antiviral Agent against Arboviruses. Viruses 14:7, pages 1381.
Crossref
Crossref
Tianxiao Wang, Pengying Zhang, Lu Chen, Huijie Qi, Haifei Chen, Yongjun Zhu, Liudi Zhang, Mingkang Zhong, Xiaojin Shi & Qunyi Li. (2022) Ixazomib Induces Apoptosis and Suppresses Proliferation in Esophageal Squamous Cell Carcinoma through Activation of the c-Myc/NOXA Pathway. Journal of Pharmacology and Experimental Therapeutics 380:1, pages 15-25.
Crossref
Crossref
Xuetong Chu, Yizhi Bu & Xiaoping Yang. (2021) Recent Research Progress of Chiral Small Molecular Antitumor-Targeted Drugs Approved by the FDA From 2011 to 2019. Frontiers in Oncology 11.
Crossref
Crossref
Anna N. Tevyashova & Mikhail V. Chudinov. (2021) Progress in the medicinal chemistry of organoboron compounds. Russian Chemical Reviews 90:4, pages 451-487.
Crossref
Crossref
Jing Zhang, Ye Zhou, Nan Li, Wan‐Ting Liu, Jun‐Ze Liang, Yue Sun, Wei‐Xia Zhang, Run‐Dong Fang, Sheng‐Ling Huang, Zheng‐Hua Sun, Yang Wang & Qing‐Yu He. (2020) Curcumol Overcomes TRAIL Resistance of Non‐Small Cell Lung Cancer by Targeting NRH:Quinone Oxidoreductase 2 (NQO2). Advanced Science 7:22, pages 2002306.
Crossref
Crossref
Chunyan Liu & Aihua Zhang. (2020)
ROS
‐mediated
PERK‐eIF2α‐ATF4
pathway plays an important role in arsenite‐induced L‐02 cells apoptosis via regulating
CHOP‐DR5
signaling
. Environmental Toxicology 35:10, pages 1100-1113.
Crossref
Crossref
Zhenhua Li, Xin Tang, Lingfei Zhu, Xiaojie Qi, Gang Cao & Gang Lu. (2020) Cytotoxic Screening and Transcriptomics Reveal Insights into the Molecular Mechanisms of Trihexyl Phosphate-Triggered Hepatotoxicity. Environmental Science & Technology 54:18, pages 11464-11475.
Crossref
Crossref
Kyoung-jin Min, Seon Min Woo, Sk Abrar Shahriyar & Taeg Kyu Kwon. (2019) Elucidation for modulation of death receptor (DR) 5 to strengthen apoptotic signals in cancer cells. Archives of Pharmacal Research 42:1, pages 88-100.
Crossref
Crossref